PRESS & MEDIA KIT

THE STORY OF
GENEPAWS.AI

GenePaws.AI is the first platform to combine pet DNA sequencing with a fully transparent, COA-verified supplement line. We exist because pet health deserves the same precision medicine revolution that human health is experiencing.

For Journalists & Editors

STORY ANGLES

Six distinct editorial angles for covering GenePaws.AI β€” from pet tech to consumer safety to veterinary medicine.

🧬

The First DNA-Triggered Pet Supplement Protocol

GenePaws.AI is the first platform to combine pet genomic sequencing with a proprietary liquid supplement line that is triggered by the pet's actual DNA results β€” not guesswork. Every supplement recommendation is generated by AI, reviewed by a board-certified veterinary nutritionist (DACVN), and traceable to a published scientific study.

Pet TechGenomicsPrecision Medicine
Quick Reference

COMPANY FACT SHEET

GenePaws.AI

GenePaws.AI β€” Company Fact Sheet

Company Name

GenePaws.AI

Parent Company

Gmax Central, LLC (also operates Cleverpetz)

Headquarters

500 Westover Dr #92909, Sanford, NC 27330

Founded

2024

Funding Stage

Pre-Seed / Bootstrapped (Seed round in preparation)

Industry

Pet Health Technology, Animal Dietary Supplements, Genomics

Business Model

DTC e-commerce + DNA testing kit + AI supplement protocol platform

Product Count

35 proprietary liquid supplement SKUs (Phase 1) + 6 DNA kits across 6 species

Supplement Format

Liquid drops (all products) β€” 85–98% bioavailability vs. 5–18% for capsules

DNA Panel

247,000+ SNP markers β€” canine flagship; 200,000+ feline; equine, reptile, avian, aquatic

Veterinary Oversight

All protocols reviewed by DACVN-credentialed veterinarians

Certifications (Target)

NASC Quality Seal, Non-GMO, Leaping Bunny, Certified Vegan

Key Differentiator

DNA-triggered supplement protocol + QR-linked COA verification on every bottle

Website

genepaws.ai

Press Contact

[email protected]

Download Assets

BRAND ASSETS

All assets are available in the press kit PDF. Contact [email protected] for individual file requests.

GenePaws.AI Logo on White

Primary Logo β€” Light Background

⬇ Download PNG
GenePaws.AI Logo on Dark

Logo β€” Dark Background

⬇ Download PNG

Brand Color Palette

Navy

#1e3a5f

Pantone 289 C

Primary brand color β€” headings, nav, CTAs

Sky Blue

#0ea5e9

Pantone 299 C

Accent β€” links, badges, highlights

Cyan

#22d3ee

Pantone 305 C

Secondary accent β€” gradient, DNA elements

White

#ffffff

White

Background, text on dark

Slate

#f8fafc

Pantone Cool Gray 1 C

Section backgrounds

Charcoal

#1e293b

Pantone 432 C

Body text, dark sections

πŸ”΅

Primary Logo (PNG)

Full-color GenePaws.AI logo on white background

PNG
⬛

Logo on Dark (PNG)

White logo for dark backgrounds

PNG
🎨

Brand Color Palette

Navy (#1e3a5f), Sky Blue (#0ea5e9), White (#ffffff), Slate (#f8fafc)

PDF / ASE
πŸ”€

Typography Guide

Space Grotesk (headings), Inter (body)

PDF
πŸ“Έ

Product Photography

High-resolution product shots on white and lifestyle backgrounds

JPG / PNG
🐾

Lifestyle Photography

Dogs, cats, horses, and owners with GenePaws.AI products

JPG
🧬

DNA & Science Illustrations

Custom infographics explaining the DNA-to-supplement process

PNG / SVG
πŸ“‹

Brand Guidelines PDF

Complete brand usage guide including do's and don'ts

PDF
News

PRESS RELEASES

February 2026

EMBARGOED β€” available upon request

GenePaws.AI Launches First DNA-Triggered Pet Supplement Platform with QR-Verified COA on Every Bottle

GenePaws.AI today announced the public launch of its DNA-triggered pet supplement platform, combining 247,000-marker genomic sequencing with a fully transparent supplement line verified by third-party Certificates of Analysis.

Q2 2026 (Planned)

UPCOMING

GenePaws.AI Announces Seed Round and Expansion to Wholesale Retail Network

GenePaws.AI plans to announce its seed funding round and the launch of its wholesale program targeting independent pet retailers across the United States.

Q3 2026 (Planned)

UPCOMING

GenePaws.AI Receives NASC Quality Seal β€” First DNA-Supplement Platform to Achieve Certification

GenePaws.AI is pursuing NASC Quality Seal certification, which would make it the first DNA-triggered supplement platform to achieve this industry standard.

Copy & Paste

COMPANY BOILERPLATE

Standard description for use in articles, press releases, and media coverage.

GenePaws.AI is the first DNA-triggered pet supplement platform, combining 247,000-marker genomic sequencing with a fully transparent supplement line verified by third-party Certificates of Analysis (COA). Every supplement protocol is generated by AI and reviewed by a board-certified veterinary nutritionist (DACVN) before delivery. All products are formulated as liquid drops for maximum bioavailability and carry a QR code linking to the live COA for that specific batch. GenePaws.AI is operated by Gmax Central, LLC, headquartered in Sanford, NC. For more information, visit genepaws.ai.

The Science Behind GenePaws.AI

247,000+ GENETIC MARKERS.
ONE PERFECT PROTOCOL.

GenePaws.AI's SNP microarray analyzes 247,000+ genetic markers in dogs and 200,000+ in cats β€” identifying breed composition, hereditary health risks, drug sensitivities, and physical trait predictions. The AI engine maps these results to our 35-product proprietary supplement catalog and generates a personalized protocol reviewed by a licensed veterinarian.

247K+

Genetic Markers

6

Species Covered

35

Proprietary SKUs

100%

Vet Review

DNA Science
Get in Touch

MEDIA CONTACTS

General Press Inquiries

Press Team

[email protected]

Story pitches, interview requests, product samples, general media inquiries

⏱ Response within 4 business hours

Investor & Business Media

Cedric Leyniers, Founder & CEO

[email protected]

Investor relations, business strategy, funding announcements

⏱ Response within 1 business day

Science & Veterinary Media

Science Team

[email protected]

Technical questions about DNA methodology, supplement formulation, COA verification

⏱ Response within 2 business days

πŸ“‹ Editorial Guidelines

  • β€’ All product claims must be attributed to GenePaws.AI and not presented as independently verified unless a journalist has conducted their own testing.
  • β€’ The GenePaws.AI AI model is described as a "supplement recommendation engine" β€” not a diagnostic tool. Please do not describe it as diagnosing medical conditions.
  • β€’ Veterinary review is performed by DACVN-credentialed professionals. Please do not describe reviewers as "doctors" without specifying veterinary context.
  • β€’ COA data is third-party verified. Journalists are welcome to request any COA for independent review.
  • β€’ Embargo requests are honoured. Please confirm embargo terms in writing before receiving embargoed materials.
πŸ“¬ Media Kit Request

REQUEST THE FULL MEDIA KIT

Enter your details below and we'll send you the full press kit PDF β€” including brand assets, founder bios, product catalog, and company fact sheet β€” instantly.

By submitting, you agree to receive the GenePaws.AI press kit and occasional media updates. Unsubscribe anytime.